Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

Roche - Basel

Roche boosts cancer portfolio with $1bn Blueprint deal

Collaboration will focus on the development of its ‘immunokinases’ immuno-oncology treatment

- PMLiVE

Valeant shares slide on fears of filing default

Cuts revenue forecasts for 2016 following report of fourth-quarter loss

- PMLiVE

Social media and inflation penalties for generic drugs

US generic drug companies are under more scrutiny as the US public becomes more vocal 

- PMLiVE

Sally Waterman appointed as chair of OBN

She succeeds David Laskow-Pooley

- PMLiVE

Mary Briggs moves from Covance to eClinicalHealth

Becomes head of business development and North American operations

- PMLiVE

Pharma needs to ‘better articulate’ its value to society

And that includes its need to finance new medical discoveries by making a profit

- PMLiVE

FDA allows accelerated review for rivals to over-priced drugs

Aims to combat growing trend in exploitation of sole-source drug pricing

- PMLiVE

GW ascendant as epilepsy drug clears phase III trial

Epidiolex proves effective in controlling seizures in children with Dravet syndrome

- PMLiVE

Focus on multiple myeloma treatment: Witnessing a transformation

Consultant David Cooney of Blue Latitude Health will take you through how that transformation has happened, and where the treatment of multiple myeloma is heading.

Blue Latitude Health

- PMLiVE

NeuroVive appoints new chief executive officer

Erik Kinnman succeeds Jan Nilsson

- PMLiVE

Building the capabilities for a new ‘patient access’ model

Equipping employees for purpose-driven performance

Genoscience Pharma expands board of directors

Robert Duggan, Chaim Hurvitz, Manmeet Soni and Mahkam Zanganeh join the firm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links